Tamoxifen Agonism and Estrogen Antagonism of c-fos Gene Promoter Activity through Non-Consensus-Responsive Elements in MC3T3-E1 Osteoblasts
- 1 December 2001
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 289 (3) , 705-711
- https://doi.org/10.1006/bbrc.2001.6045
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Ligand-, Cell-, and Estrogen Receptor Subtype (α/β)-dependent Activation at GC-rich (Sp1) Promoter ElementsJournal of Biological Chemistry, 2000
- A Trans-Acting Enhancer Modulates Estrogen-Mediated Transcription of Reporter Genes in OsteoblastsJournal of Bone and Mineral Research, 1999
- Tamoxifen up-regulates oestrogen receptor-α, c-fos and glyceraldehyde 3-phosphate-dehydrogenase mRNAs in ovine endometriumThe Journal of Steroid Biochemistry and Molecular Biology, 1998
- Oestrogen receptor beta (ER beta)Reviews of Reproduction, 1998
- Differential Ligand Activation of Estrogen Receptors ERα and ERβ at AP1 SitesScience, 1997
- Agonistic Effect of Tamoxifen Is Dependent on Cell Type, ERE-Promoter Context, and Estrogen Receptor Subtype: Functional Difference between Estrogen Receptors α and βBiochemical and Biophysical Research Communications, 1997
- Characterization of the Molecules Involved in the Hematopoietic Microenvironment Provided by Mouse Stromal Cell Line MC3T3-G2/PA6 Using a Unique Reporter System That Analyzes the Direct Cell-to-Cell InteractionActa Haematologica, 1997
- ERβ: Identification and characterization of a novel human estrogen receptorFEBS Letters, 1996
- Cloning of a novel receptor expressed in rat prostate and ovary.Proceedings of the National Academy of Sciences, 1996
- Presence of an estradiol response region in the mouse c-fos oncogeneSteroids, 1991